Epstein Secrets

nnual Meeting EFTA_R1_02010989 EFTA02686115 John P. Connolly John Conroy Chief Executive Officer, United Kingdom, Deloitte and Chairman of the Global Board Head, Global Strategic Initiatives Baker & McKenzie United Kingdom USA Jerome Contamine Executive Vice-President and Chief Sanofi-Aventis Fra

herine M. Gehl Horst F. Geicke Jurgen M. Geissinger Paul Geitner Bekele Geleta Richard L. Gelfond Eli Gelman Pierre Gentin William W. George Julie Louise Gerberding David R. Gergen Valery Gergiev Valerie Germain Nataliya Germanova Tillman U. Gerngross Olaf Gersemann Minelik Getahun Aart J. Geu

eneral, World Intellectual Property Organization (WIPO). Geneva Klaus-Peter Gushurst Senior Vice-President, Director of Booz & Company Germany Global Board Antonio Guterres UN High Commissioner for Refugees, Geneva Amy Gutmann President University of Pennsylvania USA Karl-Theodor Freiherr zu Fed

rre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA V

eneral, World Intellectual Property Organization (WIPO). Geneva Klaus-Peter Gushurst Senior Vice-President, Director of Booz & Company Germany Global Board Antonio Guterres UN High Commissioner for Refugees, Geneva Amy Gutmann President University of Pennsylvania USA Karl-Theodor Freiherr zu Fed

rre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA V